Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.20.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.20.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.20.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.20.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.20.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.20.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.20.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.110EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.110ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.110ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.110EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.110EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.110ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XCF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCF.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCF.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCF.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCF.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JC.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JC.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JC.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JC.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JC.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JC.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used